Mehdi Gasmi MS, PhD

Mehdi Gasmi, Ph.D. is Adverum’s chief science and technology officer. He joined the Company in 2013 and leads process development, manufacturing, and quality control functions for Adverum’s gene therapy product candidates. He is also responsible for the development of Adverum’s novel vector technology platform. A gene therapy veteran, Dr. Gasmi has worked in the field since 1996 at various academic institutions, including City of Hope and the University of California, San Diego, and at gene therapy companies, including Chiron, Cell Genesys, and Ceregene. Dr. Gasmi has extensive experience in the design, development and manufacturing of lentiviral and recombinant AAV vectors for clinical applications. Prior to Adverum, Dr. Gasmi was vice president of biomanufacturing at Genethon. He received a M.S. and Ph.D. in Biochemistry from the Claude Bernard University in Lyon, France.